Vivani Medical, Inc. (VANI)

Name: Vivani Medical, Inc. (VANI) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001266806 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

Sector Manufacturing
Incorporated DE
Fiscal year ends Dec 31

For the year ended 2025-12-31, Vivani Medical, Inc. reported revenue of $0.

Key ratios (year ended 2025-12-31)

-169.2%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	n/a	$0	$0	n/a	n/a	n/a	n/a	$3.38M	$6.90M	$7.96M	$3.98M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	$130.0K	$500.0K	$2.15M	$4.89M	$5.12M	$10.08M
Gross Profit	n/a	n/a	n/a	n/a	n/a	$130.0K	$500.0K	$1.23M	$2.01M	$2.85M	-$6.09M
R&D Expense	$18.11M	$18.13M	$15.74M	$16.97M	$14.17M	$11.00M	$4.84M	$13.14M	$10.01M	$7.89M	$5.35M
Operating Income	-$27.36M	-$27.56M	-$24.68M	-$26.96M	-$21.24M	-$13.32M	-$14.90M	-$33.95M	-$35.18M	-$28.61M	-$33.21M
Depreciation & Amortization	n/a	$424.0K	$400.0K	$357.0K	$381.0K	$345.0K	$164.0K	$397.0K	$435.0K	$457.0K	$432.0K
EBITDA	n/a	-$27.13M	-$24.28M	-$26.61M	-$20.86M	-$12.98M	-$14.73M	-$33.56M	-$34.74M	-$28.15M	-$32.78M
Net Income	-$26.31M	-$26.61M	-$23.49M	-$25.65M	-$13.89M	-$12.77M	-$14.88M	-$33.59M	-$35.09M	-$28.52M	-$33.18M
EPS (Diluted)	n/a	-$0.43	-$0.43	-$0.50	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Assets	$41.64M	$39.39M	$41.56M	$45.80M	$51.13M	$5.45M	$4.46M	$16.60M	$10.68M	$14.50M	$16.81M
Total Liabilities	$22.67M	$23.66M	$23.95M	$25.04M	$6.82M	$2.99M	$5.13M	$9.32M	$7.60M	n/a	n/a
Shareholders' Equity	$18.97M	$15.73M	$17.61M	$20.76M	$44.31M	$2.46M	-$672.0K	$7.28M	$3.08M	$7.88M	$11.15M
Cash & Equivalents	$19.89M	$16.23M	$18.35M	$20.65M	$45.08M	$69.59M	$3.18M	$11.33M	$4.47M	$7.84M	$10.88M
Operating Cash Flow	-$25.30M	-$24.32M	-$20.79M	-$23.70M	-$18.79M	-$10.95M	-$16.82M	-$27.63M	-$29.81M	-$23.95M	-$25.07M
Capital Expenditures	$1.20M	$1.17M	$556.0K	$887.0K	$338.0K	$572.0K	$330.0K	$493.0K	$163.0K	$265.0K	$490.0K
Free Cash Flow	-$26.50M	-$25.49M	-$21.34M	-$24.59M	-$19.12M	-$11.52M	-$17.15M	-$28.12M	-$29.97M	-$24.21M	-$25.56M
Shares Outstanding	89.41M	76.43M	59.23M	51.03M	50.7K	36.80M	23.2K	15.64M	9.54M	57.63M	42.70M
Weighted Average Diluted Shares	n/a	62.39M	54.98M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EPS (Basic)	n/a	-$0.43	-$0.43	-$0.50	n/a	n/a	n/a	n/a	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView